There is such a common theme on spec'stocks.
Once they are in the top 4 most discussed list it becomes an over hyped honey trap with many unable or are too lazy to DYOR. People want easy money, instantly for no hard work.
The list is endless, XPE, SYT,IOT, UNS,...(add your own)
Then what happens is a constant bombardment of analising every pip move and constant repetition of what we already know and omitting any new thoughts or new analysis. It becomes desperado.
Just like a horse racing commentator as what he says is irrelevant until he declares the winner or loser.
The more hyped the bigger the fall.
The best way to use HC is DYOR, then and only then check the number of posts, the less the better.
- Forums
- ASX - By Stock
- ELE
- Ann: Commercial Purchase Order Received
Ann: Commercial Purchase Order Received, page-229
-
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ELE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.27M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
ELE (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online